Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

LLY

Lilly(Eli) & Co

Feb 12 • 12:41PM ET

1,046.94

+31.73 3.12 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN-D AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV VUG SPY XLV VIG IWF VHT IVW

Index	S&P 500	P/E	45.61	EPS (ttm)	22.96	Insider Own	9.93%	Shs Outstand	945.38M	Perf Week	2.56%
Market Cap	989.76B	Forward P/E	25.33	EPS next Y	41.33	Insider Trans	-3.93%	Shs Float	851.51M	Perf Month	-2.81%
Enterprise Value	1022.41B	PEG	0.95	EPS next Q	7.21	Inst Own	73.47%	Short Float	0.82%	Perf Quarter	5.90%
Income	20.64B	P/S	15.19	EPS this Y	39.72%	Inst Trans	-0.71%	Short Ratio	2.06	Perf Half Y	58.51%
Sales	65.18B	P/B	41.62	EPS next Y	22.17%	ROA	19.33%	Short Interest	6.98M	Perf YTD	-2.58%
Book/sh	25.16	P/C	99.84	EPS next 5Y	26.53%	ROE	96.82%	52W High	1133.95 -7.67%	Perf Year	19.93%
Cash/sh	10.49	P/FCF	106.75	EPS past 3/5Y	49.25% 27.59%	ROIC	31.91%	52W Low	623.78 67.84%	Perf 3Y	203.35%
Dividend Est.	6.74 (0.64%)	EV/EBITDA	36.14	Sales past 3/5Y	31.69% 21.58%	Gross Margin	85.40%	Volatility	4.09% 3.32%	Perf 5Y	405.06%
Dividend TTM	6.00 (0.57%)	EV/Sales	15.69	EPS Y/Y TTM	120.94%	Oper. Margin	45.56%	ATR (14)	40.35	Perf 10Y	1368.97%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	1.24	Sales Y/Y TTM	44.70%	Profit Margin	31.66%	RSI (14)	50.17	Recom	1.53
Dividend Gr. 3/5Y	15.24% 15.18%	Current Ratio	1.55	EPS Q/Q	58.78%	SMA20	0.21%	Beta	0.40	Target Price	1236.73
Payout	26.14%	Debt/Eq	1.79	Sales Q/Q	42.56%	SMA50	-0.31%	Rel Volume	0.78	Prev Close	1015.21
Employees	47000	LT Debt/Eq	1.72	Earnings	Feb 04 BMO	SMA200	21.33%	Avg Volume	3.39M	Price	1046.94
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.10% 7.51%	Trades		Volume	1,368,083	Change	3.12%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025

Show Previous Ratings

Today 10:09AM	The Zacks Analyst Blog Highlights Eli Lilly, Marriott International, Fortinet, GSI Technology and Kewaunee Scientific (Zacks)
10:00AM	2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off (24/7 Wall St.)
08:42AM	How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report (Zacks)
08:03AM	VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates (Zacks)
08:02AM	McDonald's gears up to battle GLP-1 weight-loss drug pills (Yahoo Finance)
08:02AM	Loading…
08:02AM	'We know that consumers' behavior changes': McDonald's prepares for wider GLP-1 adoption as weight-loss pills hit market (Yahoo Finance)
07:02AM	West Pharma forecasts 2026 profit above estimates on strong demand for drug components (Reuters)
04:23AM	Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs (Benzinga)
03:00AM	Lillys $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift (Pharma Voice)
Feb-11-26 08:39PM	Inspire Medical Systems Q4 Earnings Call Highlights (MarketBeat)
07:38PM	Eli Lilly and Company (LLY) to Acquire Orna Therapeutics in $2.4B Deal to Expand RNA Pipeline (Insider Monkey)
06:00PM	PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co (GuruFocus.com)
04:14PM	Top Analyst Reports for Eli Lilly, Marriott & Fortinet (Zacks)
02:26PM	Robust Demand for Eli Lilly and Company (LLY)'s Obesity and Diabetes Treatments Drives Strong Investor Sentiment (Insider Monkey)
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
09:54AM	Loading…
09:54AM	Is Novo Nordisk's Turnaround Story at Risk After Weak 2026 Outlook? (Zacks)
08:59AM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
01:48AM	Analyst Report: Incyte Corporation (Morningstar Research)
12:41AM	The Top 5 Analyst Questions From Eli Lilly's Q4 Earnings Call (StockStory)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
04:01PM	Gilead's Earnings Surprise. HIV Drug Sales Were Strong. (Barrons.com)
03:48PM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
11:10AM	LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal (Zacks)
10:49AM	Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026 (Zacks)
10:38AM	INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales (Zacks)
07:13AM	Nektar, continuing comeback, says eczema drugs effects hold up in follow-up study (BioPharma Dive)
12:01AM	Novo Nordisk Launches Suit to Knock Out Hims & Hers Weight Loss Knockoffs (The Daily Upside)
Feb-09-26 03:13PM	Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion (Barrons.com)
02:19PM	Novo Nordisk Escalates Fight Against Hims & Hers (The Wall Street Journal)
01:19PM	Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion (The Wall Street Journal)
01:00PM	Loading…
01:00PM	Eli Lilly bets on in vivo cell therapy in $2.4bn Orna Therapeutics buyout (Pharmaceutical Technology)
12:28PM	Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans (Benzinga)
11:25AM	Novo sues Hims & Hers despite Wegovy pill offering U-turn (Pharmaceutical Technology)
10:49AM	Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds (Yahoo Finance)
10:24AM	Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit (Investor's Business Daily)
10:12AM	Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why (Investor's Business Daily)
09:55AM	Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead? (Zacks)
09:37AM	Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill (The Wall Street Journal)
09:28AM	Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges (Yahoo Finance Video)
09:15AM	Unlocking Lilly (LLY) International Revenues: Trends, Surprises, and Prospects (Zacks)
09:11AM	Eli Lilly Bets $2.4 Billion On Small Biotech To Boost Future Cell Treatments (Benzinga)
09:11AM	Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? (Zacks)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:12AM	Hims & Hers Stock Plunges. Its Weight Loss Drug Strategy Backfired. (Barrons.com)
07:29AM	Eli Lilly Pays $350 Million Upfront in China Biotech Collaboration Deal (GuruFocus.com)
07:18AM	Eli Lilly Stock Rises. It's Acquiring This Cell Therapy Company for $2.4 Billion. (Barrons.com)
07:09AM	Lilly to buy Orna Therapeutics for up to $2.4 billion (Reuters)
07:00AM	Lilly to acquire Orna Therapeutics to advance cell therapies (PR Newswire)
06:42AM	Lilly Deepens Longtime Innovent Partnership (GuruFocus.com)
06:01AM	Innovent and Lilly to advance new oncology and immunology medicines (Pharmaceutical Technology)
02:45AM	Novo Nordisk shares rise as Hims abandons $49 weight-loss pill (Reuters)
12:57AM	Innovent Biologics Strikes Partnership Deal With Eli Lilly (The Wall Street Journal)
Feb-08-26 01:31PM	Eli Lilly (LLY) is "the Great Drug Company on Earth," Says Jim Cramer (Insider Monkey)
10:26AM	Analysts Project Eli Lilly (LLY) to Deliver 21%+ Revenue Growth and 40%+ Adjusted Earnings Growth in 2026 (Insider Monkey)
Feb-07-26 05:22PM	Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown (Investor's Business Daily)
08:33AM	Goldman Sachs Reaffirms Buy on Eli Lilly and Company (LLY), Citing 25% Growth Outlook (Insider Monkey)
05:30AM	The Weight-Loss Price Wars Are Breaking Big Pharma's Business Model (The Wall Street Journal)
12:56AM	Jim Cramer Says "Eli Lilly's Constantly Taking Share From Danish Novo Nordisk" (Insider Monkey)
Feb-06-26 05:45PM	Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut (MarketBeat)
05:13PM	TrumpRx Is Here. Most People Won't Benefit. (Barrons.com)
04:13PM	Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers (Barrons.com)
01:52PM	CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder (Benzinga)
12:53PM	Big-Name Earnings, Selloffs Highlight Busy Week on Wall Street (Schaeffer's Research)
12:38PM	These Stocks Are Todays Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More (Barrons.com)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:52AM	Hims & Hers Stock Drops. It May Be Losing Its Weight-Loss Battle With Novo. (Barrons.com)
11:27AM	Stock Market Divided With S&P 500, Nasdaq Below Key Levels; Google, Amazon AI Spending Stuns: Weekly Review (Investor's Business Daily)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
10:29AM	Eli Lilly Stock Jumps on Wave of Analysts Upgrade (GuruFocus.com)
09:45AM	Eli Lilly (LLY) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:27AM	NVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill (Zacks)
08:23AM	Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
08:00AM	China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse. (Investor's Business Daily)
07:52AM	Novos Stratospheric Rise Has Turned Into a $460 Billion Wipeout (Bloomberg)
07:50AM	Multiple Tailwinds Lifted Eli Lilly and Company (LLY) in Q4 (Insider Monkey)
07:04AM	Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. (Barrons.com)
06:47AM	Amazon Defies AI Fears With Huge Spending. Why It's a Big Risk for Markets. (Barrons.com)
05:32AM	US equity fund inflows ease as tech selloff weighs (Reuters)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 11:33PM	Walmarts $1T valuation: A bet on high-income shoppers (TheStreet) -7.79%
09:17PM	Trump launches TrumpRX website offering discounted prescription drugs (Investing.com)
08:24PM	White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications (The Wall Street Journal)
07:52PM	Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem (Investor's Business Daily)
05:22PM	Pfizer Pops on Q4 Results-But This May Be the Catalyst That Matters Most (MarketBeat)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
04:11PM	Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks (Investopedia)
04:08PM	Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly (Reuters)
01:49PM	Lilly stops development of three drugs, including gene therapy (Clinical Trials Arena)
01:44PM	Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst (Benzinga)
01:15PM	Hims & Hers offers cheaper weight-loss pill in a shock to Novo (Reuters Videos)
11:56AM	Why Eli Lilly (LLY) Shares Are Getting Obliterated Today (StockStory)
11:56AM	Hims & Hers Is Introducing a Cheaper Wegovy Copycat. Novo Nordisk Stock Falls. (Barrons.com)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
09:51AM	Hims Is Already Knocking Off Novo's Wegovy Pill - For Just $49 A Month (Investor's Business Daily)
09:36AM	Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall (Investing.com)
09:34AM	The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles (MarketBeat)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:26AM	Eli Lilly and Company Q4 Earnings Call Highlights (MarketBeat)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM

IFF International Flavors & Fragrances Inc daily Stock Chart

Peers: APD PPG DD ADM FMC DSM TSE ANDE FUTU RKT

| Held by: VTI VOO VO IVV SPY RSP XLB VTV VOE IWR

Index	S&P 500	P/E	-	EPS (ttm)	-1.62	Insider Own	2.00%	Shs Outstand	256.30M	Perf Week	10.69%
Market Cap	20.81B	Forward P/E	16.80	EPS next Y	4.84	Insider Trans	0.06%	Shs Float	250.98M	Perf Month	16.76%
Enterprise Value	26.92B	PEG	1.75	EPS next Q	1.16	Inst Own	96.73%	Short Float	3.98%	Perf Quarter	24.45%
Income	-412.00M	P/S	1.88	EPS this Y	6.28%	Inst Trans	0.28%	Short Ratio	5.01	Perf Half Y	22.20%
Sales	11.07B	P/B	1.46	EPS next Y	8.38%	ROA	-1.48%	Short Interest	10.00M	Perf YTD	20.61%
Book/sh	55.56	P/C	33.52	EPS next 5Y	9.59%	ROE	-2.84%	52W High	86.96 -6.53%	Perf Year	-4.02%
Cash/sh	2.42	P/FCF	62.70	EPS past 3/5Y	-4.88% -24.99%	ROIC	-2.11%	52W Low	59.14 37.43%	Perf 3Y	-14.28%
Dividend Est.	1.69 (2.08%)	EV/EBITDA	12.80	Sales past 3/5Y	-0.49% 17.44%	Gross Margin	31.15%	Volatility	2.30% 2.44%	Perf 5Y	-39.37%
Dividend TTM	1.60 (1.97%)	EV/Sales	2.43	EPS Y/Y TTM	82.30%	Oper. Margin	9.85%	ATR (14)	2.21	Perf 10Y	-23.86%
Dividend Ex-Date	Dec 19, 2025	Quick Ratio	0.86	Sales Y/Y TTM	-3.01%	Profit Margin	-3.72%	RSI (14)	77.78	Recom	1.82
Dividend Gr. 3/5Y	-19.96% -11.58%	Current Ratio	1.44	EPS Q/Q	-32.23%	SMA20	11.21%	Beta	1.03	Target Price	81.30
Payout	168.56%	Debt/Eq	0.47	Sales Q/Q	-7.90%	SMA50	17.24%	Rel Volume	1.45	Prev Close	76.97
Employees	22400	LT Debt/Eq	0.37	Earnings	Feb 11 AMC	SMA200	16.95%	Avg Volume	2.00M	Price	81.28
IPO	Mar 02, 1964	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.32% 3.00%	Trades		Volume	1,495,982	Change	5.60%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Aug-07-25	Downgrade	Oppenheimer	Outperform → Perform
Jun-04-25	Initiated	Tigress Financial	Buy	$105
May-08-25	Upgrade	Barclays	Equal Weight → Overweight	$84
Feb-20-25	Downgrade	CFRA	Buy → Sell	$77
Jan-07-25	Upgrade	Argus	Hold → Buy
Nov-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$111 → $110
Nov-08-24	Upgrade	BofA Securities	Neutral → Buy	$107
Nov-07-24	Upgrade	Vertical Research	Hold → Buy	$109
Sep-11-24	Reiterated	Oppenheimer	Outperform	$116 → $117
Sep-03-24	Upgrade	Mizuho	Neutral → Outperform	$109 → $120
Jul-22-24	Upgrade	Stifel	Hold → Buy	$95 → $115
Jun-07-24	Initiated	Oppenheimer	Outperform	$116
May-21-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$100
May-08-24	Upgrade	JP Morgan	Neutral → Overweight	$75 → $100
Apr-18-24	Upgrade	Barclays	Underweight → Equal Weight
Apr-10-24	Upgrade	Citigroup	Neutral → Buy	$81 → $100
Mar-08-24	Downgrade	Argus	Buy → Hold
Mar-01-24	Initiated	Wolfe Research	Underperform
Jan-22-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$81 → $90

Show Previous Ratings

Today 08:30AM	International Flavors & Fragrances Inc. Q4 2025 Earnings Call Summary (Moby) +5.60%
Feb-11-26 06:00PM	International Flavors (IFF) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	International Flavors (IFF) Q4 Earnings Miss Estimates (Zacks)
04:48PM	International Flavors & Fragrances's (NYSE:IFF) Q4 CY2025 Sales Top Estimates (StockStory)
04:35PM	International Flavors: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Loading…
04:15PM	IFF Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-09-26 10:01PM	International Flavors & Fragrances (IFF) Q4 Earnings Report Preview: What To Look For (StockStory)
10:11AM	International Flavors to Report Q4 Earnings: What's in Store? (Zacks)
Feb-06-26 09:15AM	International Flavors (IFF) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Feb-05-26 08:40AM	Green Plains Renewable Energy (GPRE) Q4 Earnings Surpass Estimates (Zacks)
Feb-04-26 10:00AM	International Flavors (IFF) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks) +5.56%
Feb-02-26 08:15AM	Tastepoint by IFF Predicts Ten Flavor Trends for 2026 (Business Wire)
Jan-29-26 11:02PM	International Flavors & Fragrances (IFF): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Jan-27-26 11:04PM	3 Reasons IFF is Risky and 1 Stock to Buy Instead (StockStory)
Jan-23-26 09:35AM	IFF price target raised to $80 from $70 at Argus (TipRanks)
09:02AM	Loading…
09:02AM	Potential Rate Cuts to Drive Momentum for International Flavors & Fragrances (IFF) (Insider Monkey)
Jan-21-26 04:15PM	IFF to Release Fourth Quarter & Full Year 2025 Results on Feb. 11, 2026; IFF to Present at 2026 CAGNY Conference on Feb. 19, 2026 (Business Wire)
Jan-18-26 11:03PM	3 Reasons to Avoid IFF and 1 Stock to Buy Instead (StockStory)
Jan-16-26 05:28AM	International Flavors & Fragrances Quarterly Earnings Preview: What You Need to Know (Barchart)
Jan-15-26 10:35PM	Q3 Earnings Roundup: International Flavors & Fragrances (NYSE:IFF) And The Rest Of The Ingredients, Flavors & Fragrances Segment (StockStory)
Jan-14-26 11:04PM	3 Reasons to Avoid IFF and 1 Stock to Buy Instead (StockStory)
Dec-31-25 10:39AM	IFF Gains From Focus on Growth Despite Low Food Ingredient Volumes (Zacks)
Dec-30-25 12:48PM	International Flavors & Fragrances (NYSE:IFF) Surprises With Q3 CY2025 Sales (StockStory)
Dec-23-25 10:02AM	Implied Volatility Surging for International Flavors Stock Options (Zacks)
Dec-10-25 03:20PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Dec-09-25 10:17AM	How Is International Flavors & Fragrances' Stock Performance Compared to Other Material Stocks? (Barchart)
Dec-04-25 11:30AM	International Flavors (IFF) Up 4.9% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-24-25 04:05PM	Mativ Announces Appointment of Seasoned Executive to Its Board of Directors (Business Wire)
Nov-23-25 08:00PM	IFF Introduces Smart Dosing Robot to Transform Fragrance Production (Business Wire)
Nov-21-25 09:22AM	Implied Volatility Surging for International Flavors Stock Options (Zacks)
09:15AM	Loading…
Nov-17-25 09:15AM	International Markets and International Flavors (IFF): A Deep Dive for Investors (Zacks)
Nov-13-25 11:35PM	Are Wall Street Analysts Bullish on International Flavors & Fragrances Stock? (Barchart)
Nov-06-25 08:17AM	Do You Believe in the Upside Potential of International Flavors & Fragrances (IFF)? (Insider Monkey)
03:00AM	IFF Benicarlo Pioneers On-Site Green Hydrogen Production Facility for Sustainable Fragrance Ingredient Manufacturing (Business Wire)
03:00AM	IFF Benicarl Pioneers On-Site Green Hydrogen Production Facility for Sustainable Fragrance Ingredient Manufacturing (Business Wire)
Nov-05-25 04:05PM	International Flavors & Fragrances Inc (IFF) Q3 2025 Earnings Call Highlights: Strong ... (GuruFocus.com)
01:11PM	International Flavors Earnings Beat Estimates in Q3, Sales Dip Y/Y (Zacks)
12:50PM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Nov-04-25 10:37PM	Wall Street gains ground amid steady flow of earnings reports, upbeat economic updates (Associated Press)
06:00PM	International Flavors (IFF) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	International Flavors (IFF) Q3 Earnings and Revenues Top Estimates (Zacks)
04:24PM	International Flavors: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	IFF Reports Third Quarter 2025 Results (Business Wire)
Nov-03-25 01:11PM	Hecla Mining to Report Q3 Results: What's in the Cards for the Stock? (Zacks)
11:50AM	B2Gold Gets Ready to Report Q3 Earnings: Here's What to Expect (Zacks)
Oct-31-25 01:14PM	SSR Mining is Set to Report Q3 Earnings: Here's What to Expect (Zacks)
Oct-30-25 06:35PM	Quaker Chemical (KWR) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	IFF Declares Dividend for Fourth Quarter 2025 (Business Wire)
06:00AM	IFF Honors Distinguished Academics Shaping the Future of Nutrition, Health and Biosciences (Business Wire)
Oct-29-25 02:14PM	International Flavors to Report Q3 Earnings: What's in the Offing? (Zacks)
Oct-28-25 10:00AM	International Flavors (IFF) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
09:10AM	Ecolab (ECL) Q3 Earnings and Revenues Beat Estimates (Zacks)
Oct-22-25 04:15PM	IFF Announces Appointment of Brett Icahn and Richard Mulligan to Board of Directors (Business Wire)
Oct-21-25 06:00AM	IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation (Business Wire)
Oct-17-25 03:48PM	Most Chemical Stocks Look Corrosive. These 3 Might Be Buys. (Barrons.com)
06:40AM	International Flavors & Fragrances Q3 2025 Earnings: What to Expect (Barchart)
Oct-15-25 12:10PM	Will International Flavors (IFF) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-14-25 04:15PM	IFF to Release Third Quarter 2025 Results on Nov. 4, 2025 (Business Wire)
Oct-11-25 10:03AM	Jim Cramer on International Flavors & Fragrances: It Used to Be a Better Company (Insider Monkey)
Oct-08-25 10:30PM	IFF Plans New Scent Creative Center in Mumbai, India (Business Wire)
Oct-03-25 06:27AM	What Do Analysts Think About International Flavors & Fragrances (IFF)? (Insider Monkey)
04:47AM	International Flavors & Fragrances Inc. (IFF) Unveils SipScape to Enhance Brand Awareness (Insider Monkey)
Oct-01-25 04:30PM	IFF secures ISO/IEC 27001 certification, elevating global trust in data security and operational excellence (Business Wire)
Sep-17-25 08:52AM	International Flavors & Fragrances Stock: Is IFF Underperforming the Materials Sector? (Barchart)
Sep-14-25 01:17AM	Wolfe Research Upgrades International Flavors & Fragrances (IFF) to Peer Perform From Underperform (Insider Monkey)
Sep-10-25 05:21AM	FORA Capital Raises Bet on International Flavors & Fragrances Inc. (IFF)'s 2026 Turnaround (Insider Monkey)
Sep-09-25 07:00AM	IFF launches interactive platform to inspire adult beverage innovation (Business Wire)
Sep-08-25 12:07PM	International Flavors' DEB Platform Announces Commercial Debut (Zacks)
05:00AM	IFF expands LMR Naturals site in Grasse, advancing naturals innovation leadership (Business Wire)
Sep-04-25 07:00AM	IFF's Designed Enzymatic Biomaterials Platform Sees First Large-Scale Use in Home Care Applications (Business Wire)
Sep-02-25 07:00AM	IFF Tackles Top Challenges in Baking at IBIE 2025 (Business Wire)
Aug-27-25 04:00AM	IFF and Reservas Votorantim Sign Bioprospecting Partnership in Brazil (Business Wire)
Aug-19-25 08:05AM	What Are Wall Street Analysts' Target Price for International Flavors & Fragrances Stock? (Barchart)
Aug-15-25 12:02PM	IFF Launches POWERFRESH ACE 2000 to Enhance Bread Sustainability (Zacks)
Aug-13-25 04:15PM	IFF to Webcast Fireside Chat at Barclays Global Consumer Staples Conference on Sept. 4 (Business Wire)
07:00AM	IFF Launches POWERFRESH ACE 2000, a Bread Fresh-Keeping Solution That Aces the Shelf-Life Test (Business Wire)
Aug-11-25 09:15AM	International Flavors (IFF) Reliance on International Sales: What Investors Need to Know (Zacks)
Aug-07-25 04:30AM	[Latest] Global Antioxidant BHT Market Size/Share Worth USD 542 Million by 2034 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-06-25 12:55PM	International Flavors Q2 Earnings Beat Estimates, Sales Dip Y/Y (Zacks) -6.32%
11:02AM	Analyst Report: International Flavors & Fragrances Inc. (Morningstar Research)
Aug-05-25 06:00PM	International Flavors (IFF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	International Flavors (IFF) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:26PM	International Flavors: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	IFF Reports Second Quarter 2025 Results (Business Wire)
Aug-01-25 12:35PM	International Flavors to Report Q2 Earnings: Here's What to Expect (Zacks)
Jul-31-25 07:42PM	Materials Dividends Spotlight: International Flavors & Fragrances' (IFF) Consistent Payouts (Insider Monkey)
Jul-30-25 04:20PM	IFF Declares Dividend for Third Quarter 2025 (Business Wire)
04:15PM	IFF Appoints Paul J. Fribourg and Jesus B. Mantas to Board of Directors (Business Wire)
Jul-29-25 10:00AM	Earnings Preview: International Flavors (IFF) Q2 Earnings Expected to Decline (Zacks)
Jul-24-25 06:00AM	IFF Introduces ENVIROCAP, a Breakthrough Scent Delivery Technology for Fabric Care (Business Wire)
Jul-18-25 07:08AM	China Food Ingredients Market Company Analysis Report 2025-2034, Featuring Archer-Daniels-Midland, Cargill, BASF, Corbion, Kerry Group, DSM-Firmenich, International Flavors & Fragrances, and Palsgaard (GlobeNewswire)
Jul-17-25 06:47AM	International Flavors & Fragrances Inc. (IFF) Unveils CHOOZIT LIFT to Enhance Cheese Making. (Insider Monkey)
02:59AM	IFF Unveils Immersive Experience Hub in Singapore to Accelerate Customer Collaboration, Product Innovation (Insider Monkey)
Jul-16-25 01:53PM	$9 Billion Hidden Empire: The Billionaire Family Quietly Buying Up the Stock Market (GuruFocus.com)
12:07PM	International Flavors & Fragrances Earnings Preview: What to Expect (Barchart)
Jul-10-25 11:48AM	Tigress Financial Assigns International Flavors & Fragrances (IFF) a Buy Rating (Insider Monkey)
12:00AM	IFF Expands Innovation Center in Singapore with New Immersive Experience Hub (Business Wire)
Jul-09-25 04:15PM	IFF to Release Second Quarter 2025 Results on Aug. 5, 2025 (Business Wire)
Jul-02-25 04:15AM	Givaudan SA and International Flavors & Fragrances Inc. Lead the US$840 Million Citrus Bioflavonoids Industry (GlobeNewswire)
Jun-26-25 03:53PM	Siegfried welcomes Erik Fyrwald, recognized leader in innovation, to its Advisory Board (PR Newswire)

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Muller Andres Roberto	President, Food Ingredients	Jan 02 '26	Option Exercise	0.00	1,825	0	1,825	Jan 05 05:33 PM
Landsman Stephen N	EVP, General Counsel	Dec 12 '25	Buy	63.48	3,100	196,788	15,100	Dec 12 04:18 PM
Finzel Ralf	EVP, Global Operations Officer	Dec 01 '25	Option Exercise	0.00	10,774	0	20,073	Dec 02 04:20 PM
Yildiz Beril	Former Officer	Nov 07 '25	Proposed Sale	62.51	4,060	253,810		Nov 07 01:28 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	Sep 02 '25	Option Exercise	0.00	13,808	0	41,288	Sep 03 06:16 PM
FRIBOURG PAUL J	Director	Aug 07 '25	Buy	64.80	15,450	1,001,183	15,450	Aug 08 06:49 PM
Fyrwald J Erik	Chief Executive Officer	Aug 07 '25	Buy	64.95	15,300	993,714	77,370	Aug 07 06:59 PM
Teles de Mendonca Ana Paula	President, Scent	Jun 02 '25	Option Exercise	0.00	643	0	3,088	Jun 04 05:38 PM
Arora Yuvraj	President, Taste & CCO	May 05 '25	Option Exercise	0.00	17,309	0	22,291	Jun 04 05:27 PM
Arora Yuvraj	President, Taste & CCO	May 01 '25	Option Exercise	0.00	3,572	0	6,810	Jun 04 05:27 PM
O'Byrne Kevin	Director	May 22 '25	Buy	76.05	4,500	342,240	7,696	May 23 04:46 PM
Teles de Mendonca Ana Paula	President, Scent	May 05 '25	Option Exercise	0.00	1,498	0	3,210	May 22 07:30 PM
Teles de Mendonca Ana Paula	President, Scent	May 01 '25	Option Exercise	0.00	1,587	0	2,523	May 22 07:30 PM
Palau Hernandez Margarita	Director	May 19 '25	Buy	77.42	850	65,807	2,393	May 20 01:33 PM
Yildiz Beril	CAO, SVP & Controller	May 19 '25	Sale	77.33	2,400	185,604	3,321	May 19 05:09 PM
Landsman Stephen N	EVP, General Counsel	May 19 '25	Buy	77.28	12,000	927,356	12,000	May 19 05:08 PM
Yildiz Beril	Officer	May 19 '25	Proposed Sale	77.33	2,400	185,604		May 19 01:12 PM
Yildiz Beril	CAO, SVP & Controller	May 05 '25	Option Exercise	0.00	849	0	6,028	May 16 09:01 PM
Yildiz Beril	CAO, SVP & Controller	May 01 '25	Option Exercise	0.00	952	0	5,523	May 16 09:01 PM
Finzel Ralf	EVP, Global Operations Officer	May 05 '25	Option Exercise	0.00	1,326	0	9,976	May 16 09:01 PM
Finzel Ralf	EVP, Global Operations Officer	May 01 '25	Option Exercise	0.00	1,984	0	9,663	May 16 09:01 PM
DeVeau Michael	EVP, CFO	May 05 '25	Option Exercise	0.00	884	0	11,048	May 16 09:01 PM
DeVeau Michael	EVP, CFO	May 01 '25	Option Exercise	0.00	1,389	0	10,874	May 16 09:01 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	May 05 '25	Option Exercise	0.00	1,768	0	28,383	May 16 09:00 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	May 01 '25	Option Exercise	0.00	2,381	0	27,817	May 16 09:00 PM
Palau Hernandez Margarita	Director	May 01 '25	Option Exercise	0.00	1,543	0	1,543	May 16 08:57 PM
O'Byrne Kevin	Director	May 01 '25	Option Exercise	0.00	1,875	0	3,590	May 16 08:56 PM
Khan Mehmood	Director	May 15 '25	Buy	75.33	4,000	301,314	4,604	May 15 05:27 PM
Fyrwald J Erik	Chief Executive Officer	May 09 '25	Buy	73.97	24,300	1,797,456	62,070	May 09 05:03 PM
Fyrwald J Erik	Chief Executive Officer	May 08 '25	Buy	74.00	700	51,797	37,770	May 09 05:03 PM
JAMISON CYNTHIA T	Director	May 01 '25	Option Exercise	0.00	604	0	604	May 05 05:51 PM
INTRIERI VINCENT J	Director	May 01 '25	Option Exercise	0.00	604	0	604	May 05 05:50 PM
Costa Mark J	Director	May 01 '25	Option Exercise	0.00	1,875	0	4,014	May 05 05:50 PM
Khan Mehmood	Director	May 01 '25	Option Exercise	0.00	604	0	604	May 05 05:47 PM
Fyrwald J Erik	Chief Executive Officer	May 01 '25	Option Exercise	0.00	15,875	0	45,175	May 05 05:46 PM
Strzelecki Angela	President, Pharma Solutions	Apr 04 '25	Option Exercise	0.00	1,761	0	10,362	Apr 07 04:17 PM
DeVeau Michael	CFO	Apr 04 '25	Option Exercise	0.00	1,993	0	10,204	Apr 07 04:16 PM
Borg Deborah	EVP, Chief Ppl&Culture Officer	Apr 04 '25	Option Exercise	0.00	4,602	0	27,981	Apr 07 04:16 PM
O'Byrne Kevin	Director	Mar 05 '25	Buy	80.44	6,500	522,833	6,500	Mar 06 05:13 PM
Fyrwald J Erik	CEO	Mar 04 '25	Buy	80.24	25,000	2,005,878	29,300	Mar 05 04:08 PM

LLY

Lilly(Eli) & Co

IFF

International Flavors & Fragrances Inc

Upgrade your FINVIZ experience